27 results on '"Sekikawa, Motoki"'
Search Results
2. Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing
3. Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study
4. Relation of overall tumor burden with severe immune-related adverse events in nivolumab plus ipilimumab treatment for lung cancer
5. Risk factors for severe immune-related adverse events after first-line pembrolizumab monotherapy or combination chemotherapy for non-small-cell lung cancer
6. Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report
7. Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor–Positive Non‐Small Cell Lung Cancer.
8. Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.
9. Exploring the Relationship Between Anorexia and Therapeutic Efficacy in Advanced Lung Cancer Treatment: A Retrospective Study
10. Risk factors for severe immune‐related pneumonitis after nivolumab plus ipilimumab therapy for non‐small cell lung cancer.
11. Real‐world first‐line treatment with pembrolizumab for non‐small cell lung carcinoma with high PD‐L1 expression: Updated analysis.
12. Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer
13. MO1-3 Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001 secondary report)
14. Prognostic impact of postoperative recurrence in patients with epidermal growth factor receptor-positive non-small cell lung cancer.
15. Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer
16. Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing
17. II. Advance in Perioperative Chemotherapy for Lung Cancer
18. Two Cases of ALK Fusion Gene-positive Lung Adenocarcinoma Treated with Brigatinib After Alectinib-induced Interstitial Lung Disease
19. A Non-small Cell Lung Cancer Patient Who Was Successfully Resuscitated After Cardiac Arrest Caused by Infusion-related Reaction with Carboplatin, Paclitaxel, Nivolumab, and Ipilimumab Therapy
20. Association of tumor burden with severe immune-related adverse events in nivolumab plus ipilimumab therapy for non-small cell lung cancer
21. P29-4 Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001)
22. Current status of first‐line treatment with pembrolizumab for non–small‐cell lung cancer with high PD‐L1 expression
23. Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: A case report
24. Successful management of severe bronchial asthma exacerbated by anti‐PD‐L1 treatment: A report of two cases
25. Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran ( BNT162b2 , Pfizer‐BioNTech )
26. Delayed local reaction at a previous injection site reaction with dupilumab
27. Pseudocirrhosis due to liver metastasis from lung adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.